Philip Morris
the Health Benefits of Smoking Cessation A Report of the Surgeon General
Fields
- Author
- Mason, J.O.
- Novello, A.C.
- Roper, W.L.
- Type
- PUBL, PUBLICATION, OTHER
- Area
- WORLDWIDE REG AFFAIRS/LIBRARY
- Site
- N403
- Named Organization
- Dartmouth Medical School
- Division of Nutrition
- Harvard Medical School
- Harvard School of Public Health
- Hhs, Dept of Health and Human Services
- in Univ
- Office of Surveillance + Analysis
- Office on Smoking + Health
- Public Health Service
- Uniformed Services Univ of the Health SC
- Univ Ma
- Univ of Ca
- Univ of Nm
- Brigham + Womens Hospital
- Cancer Epidemiology + Control
- Center for Chronic Disease Prevention +
- Centers for Disease Control
- Channing Lab
- Named Person
- Anda, R.
- Baron, J.
- Byers, T.
- Christen, A.G.
- Colditz, G.
- Davis, R.M.
- Grunberg, N.E.
- Hawk, S.A.
- Novello, A.C.
- Ockene, J.K.
- Petitti, D.B.
- Samet, J.M.
- Willet, W.C.
- Request
- Stmn/R1-036
- Stmn/R1-072
- Stmn/R1-073
- Stmn/R4-005
- Author (Organization)
- Center for Chronic Disease Prevention +
- Centers for Disease Control
- Hhs, Dept of Health and Human Services
- Office on Smoking + Health
- Public Health Service
- Master ID
- 2046398862/0490
- 2046398862-8874 Submission of Phillip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Iots Meeting on 940802 Volume 3.01
- 2046398875 2
- 2046398876-8886 Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Dsm-IV
- 2046398887 3
- 2046398888-8892 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition - Revised) Dsm-III-R
- 2046398893 4
- 2046398894-8897 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition)
- 2046398898 5
- 2046398899-8901 What Makes US Run?
- 2046398902 6
- 2046398903-8931 Chapter 5 the Neurochemical Mechanisms Underlying Nicotine Tolerance and Dependence
- 2046398932 7
- 2046398933-8994 8. The Psychopharmacological and Neurochemical Consequences of Chronic Nicotine Administration
- 2046398995 8
- 2046398997-8999 Establishing A Nicotine Threshold for Addiction
- 2046399000 9
- 2046399001-9006 Intravenous Nicotine Replacement Suppresses Nicotine Intake From Cigarette Smoking
- 2046399007 10
- 2046399008-9013 Daily Intake of Nicotine During Cigarette Smoking
- 2046399014 11
- 2046399015-9022 Stable Isotope Studies of Nicotine Kinetics and Bioavailability
- 2046399023 12
- 2046399024-9060 Biobehavioral Approaches to Smoking Control
- 2046399061 13
- 2046399062-9064 Brief Communication Preference Among Research Cigarettes with Varying Nicotine Yields
- 2046399065 14
- 2046399066-9076 Slip-Ups and Relapse in Attempts to Quit Smoking
- 2046399077 15
- 2046399078-9100 Drug Addiction As A Psychological Process
- 2046399101 16
- 2046399102-9113 Population Characteristics and Cigarette Yield As Determinants of Smoke Exposure
- 2046399114 17
- 2046399115-9123 Smoking History, Cigarette Yield and Smoking Behavior As Determinants of Smoke Exposure.
- 2046399124 Andrews Office Products Capitol Heights, Md (K) 18
- 2046399125-9216 Out of the Shadows Understanding Sexual Addiction Second Edition
- 2046399217 Andrews Office Products Capitol Heights, Md (K) 19
- 2046399218-9220 Morbidity and Mortality Weekly Report Progress in Chronic Disease Prevention Smoking Cessation During Previous Year Among Adults - United States, 900000 and 910000
- 2046399221 Andrews Office Products Capitol Heights, Md (K) 20
- 2046399222-9224 Research Report Can Carrots Be Addictive? An Extraordinary Form of Drug Dependence
- 2046399225 Andrews Office Products Capitol Heights, Md (K) 21
- 2046399226-9233 Running Addiction: Measurement and Associated Psychological Characteristic
- 2046399234 Andrews Office Products Capitol Heights, Md (K) 22
- 2046399235-9252 Goth's Medical Pharmacology
- 2046399253 Andrews Office Products Capitol Heights, Md (K)
- 2046399254-9272 An Analysis of the Addiction Liability of Nicotine
- 2046399273 Andrews Office Products Capitol Heights, Md (K) 24
- 2046399274-9283 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399284 Andrews Office Products Capitol Heights, Md (K) 25
- 2046399285-9288 the Effect of Running on Plasma Beta-Endorphin
- 2046399289
- 2046399290 Library Copy: Please Return
- 2046399291 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.02
- 2046399292 21 Andrews Office Products Capitol Heights, Md (K)
- 2046399293-9300 Running Addiction: Measurement and Associated Psychological Characteristics
- 2046399301 22 Andrews Office Products Capitol Heights, Md (K)
- 2046399302-9319 Goth's Medical Pharmacology Drug Abuse and Dependence
- 2046399320 23 Andrews Office Products Capitol Heights, Md (K)
- 2046399321-9339 An Analysis of the Addiction Liability of Nicotine
- 2046399340 24 Andrews Office Products Capitol Heights, Md (K)
- 2046399341-9350 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399351 25 Andrews Office Products Capitol Heights, Md (K)
- 2046399352-9355 the Effect of Running on Plasma B-Endorphin
- 2046399356 26 Andrews Office Products Capitol Heights, Md (K)
- 2046399357-9375 Shopaholics Serious Help for Addicted Spenders Chapter 3 Nature of Addiction
- 2046399376 27 Andrews Office Products Capitol Heights, Md (K)
- 2046399377-9380 Effect of Transdermal Nicotine Delivery As An Adjunct to Low-Intervention Smoking Cessation Theraphy
- 2046399381 28 Andrews Office Products Capitol Heights, Md (K)
- 2046399382-9394 Measuring Nicotine Dependence: A Review of the Fagerstrom Tolerance Questionnaire
- 2046399395 29
- 2046399396-9419 Tolerance Withdrawal and Dependence on Tobacco and Smoking Termination
- 2046399420 30 Andrews Office Products Capitol Heights, Md (K)
- 2046399421-9426 Methods Used to Quit Smoking in the United States Do Cessation Programs Help?
- 2046399427 31 Andrews Office Products Capitol Heights, Md (K)
- 2046399428-9434 Effect of Transdermal Nicotine Patches on Cigarette Smoking A Double Blind Crossover Study
- 2046399435 32
- 2046399435A Symposium Smoking Cessation: A Comparison of Aided Vs. Unaided Quitters / Attempters. Predictors of Early Relapse.
- 2046399436 33
- 2046399437-9448 Mind Matters How Mind and Brain Interact to Create Our Conscious Lives
- 2046399449 34
- 2046399450-9452 Cigarette Craving, Smoking Withdrawal, and Clonidine
- 2046399453 35
- 2046399454-9456 Psycological and Pharmacological Influences in Cigarette Smoking Withdrawal: Effects of Nicotine Gum and Expectancy on Smoking Withdrawal Symptoms and Relapse
- 2046399457 36
- 2046399458-9463 Crs Report for Congress Cigarette Taxes to Fund Health Care Reform: An Economic Analysis
- 2046399464 37
- 2046399465-9472 22.4 Caffeine and Tobacco Dependence
- 2046399473 38
- 2046399474-9476 Pinball Wizard: the Case of A Pinball Machine Addict
- 2046399477 39
- 2046399478-9492 Reviews Caffeine Physical Dependence: Review of Human and Laboratory Animal Studies
- 2046399493 40
- 2046399494-9498 Brief Report Reactions to Withdrawal Symptoms and Success in Smoking Cessation Clinics
- 2046399499 41
- 2046399500-9505 Nicotine or Tar Titration in Cigarette Smoking Behavior?
- 2046399506 42
- 2046399507-9511 Brief Report Blood Nicotine, Smoke Exposure and Tobacco Withdrawal Symptoms
- 2046399512 43
- 2046399513-9523 Conference Report Involvement of Tobacco in Alcoholism and Illicit Drug Use
- 2046399524 44
- 2046399525-9535 Pharmacologic Basis and Treatment of Cigarette Smoking
- 2046399536 45
- 2046399537-9550 'chocolate Addiction': A Preliminary Study of Its Description and Its Relationship to Problem Eating
- 2046399551 46
- 2046399552-9562 Smoking Cessation Methods: Recommendations for Health Professionals. Advisory Group of the European School of Oncology
- 2046399563 47
- 2046399564-9574 Nicotine Yield As Determinant of Smoke Exposure Indicators and Puffing Behavior
- 2046399575 48
- 2046399576-9581 Psychological Analysis of Establishment and Maintenance of the Smoking Habit
- 2046399582 49
- 2046399583-9586 Seminars in Respiratory Medicine Appetitive Functions and Dysfunctions: Tobacco
- 2046399587 Andrews Office Products Capitol Heights, Md (K)
- 2046399588 Endorphins, Eating Disorders and Other Addictive Behaviors
- 2046399589-9621 the Clinical Phases of Anorexia Nervosa and Their Relevance to Endorphin Addiction
- 2046399622 51
- 2046399623-9632 Pharmacotheraphy for Smoking Cessation: Unvalidated Assumptions, Anomalies, and Suggestions for Future Research
- 2046399633 52
- 2046399634-9641 Risk - Benefit Assessment of Nicotine Preparations in Smoking Cessation
- 2046399642 53
- 2046399643-9650 Should Caffeine Abuse, Dependence, or Withdrawal Be Added to Dsm - IV and Icd - 10?
- 2046399651 54
- 2046399652-9660 Tobacco Withdrawal in Self - Quitters
- 2046399661 55
- 2046399662-9669 Symptoms of Tobacco Withdrawal A Replication and Extension
- 2046399670
- 2046399671-9763 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.03 Effects of Abstinence From Tobacco A Critical Review
- 2046399764 57
- 2046399765-9769 Reports From Research Centres - 21 Human Behavioral Pharmacology Laboratory University of Vermont
- 2046399770 58
- 2046399771 Withdrawal Symptoms and Smoking Cessation
- 2046399772 59
- 2046399773-9778 Nicotine Vs Placebo Gum in General Medical Practice
- 2046399779 60
- 2046399780-9783 Prevalence of Tobacco Dependence and Withdrawal
- 2046399784 61
- 2046399785-9790 Signs and Symptoms of Tobacco Withdrawal
- 2046399791 62
- 2046399792-9798 Patterns and Predictors of Smoking Cessation Among Users of A Telephone Hotline
- 2046399799 63
- 2046399800-9820 Current Concepts of Addiction
- 2046399821 64
- 2046399822-9861 the American Academy of Psychiatrists in Alcoholism and Addictions 910000 Annual Meeting
- 2046399862 65
- 2046399863-9915 the Pharmacological Basis of Therapeutics Eighth Edition Chapter 22 Drug Addiction and Drug Abuse
- 2046399916 66
- 2046399917-9953 1 Tobacco Smoking and Nicotine Dependence
- 2046399954 67
- 2046399955-9957 Commentary Trivializing Dependence
- 2046399958 68
- 2046399959-9968 the Favorite Cigarette of the Day
- 2046399969 69
- 2046399970-9971 Overview: Alternative Forms of Pharmacologic Treatment
- 2046399972 70
- 2046399973-9974 British Medical Journal No 6891 Volume 306
- 2046399975 71
- 2046399976-9981 Original Contributors Predicting Smoking Cessation Who Will Quit with and Without the Nicotine Patch
- 2046399982 72
- 2046399983-0019 the Selling of Dsm the Rhetoric of Science in Psychiatry
- 2046400020 73
- 2046400021-0028 the Nosology of Abuse and Dependence
- 2046400029 74
- 2046400030-0035 Use and Misuse of the Concept of Craving by Alcohol, Tobacco, and Drug Researchers
- 2046400035A
- 2046400036-0045 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802
- 2046400046 75
- 2046400047-0048 What Researchers Make of What Cigarette Smokers Say: Filtering Smokers' Hot Air
- 2046400049 76
- 2046400050-0055 the Use of Flavor in Cigarette Substitutes
- 2046400056 77
- 2046400057-0060 Failure to Support the Validity of the Fagerstrom Tolerance Questionnaire As A Measure of Physiological Tolerance to Nicotine
- 2046400061 78
- 2046400062-0067 Effects of Cigarette Smoking on Electrodermal Orienting Reflexes to Stimulus Change and Stimulus Significance
- 2046400068 79
- 2046400069-0074 Behavioral (Non-Chemical) Addictions
- 2046400075 80
- 2046400076-0078 Nicotine Infused Into the Nucleus Accumbens Increases Synaptic Dopamine As Measured by in Vivo Microdialysis
- 2046400079 81
- 2046400080-0085 the Chemistry of Craving
- 2046400086 82
- 2046400087-0102 the Disease Controversy Revisited: An Ontologic Perspective
- 2046400103 83
- 2046400104-0134 A Psychopharmacological and Psychophysiological Evaluation of Smoking Motives
- 2046400135 84
- 2046400136-0146 Predictors and Reasons for Relapse in Smoking Cessation with Nicotine and Placebo Patches
- 2046400147 85
- 2046400148-0155 Clinical Trials and Therapeutics Nasal Spray Nicotine Replacement Suppresses Cigarette Smoking Desire and Behavior
- 2046400156 86
- 2046400157-0163 Predictors of Smoking Cessation in A Sample of Italian Smokers
- 2046400164 87
- 2046400165-0167 Clarification and Standardization of Substance Abuse Terminology
- 2046400168 88
- 2046400169-0179 the Role of Nicotine in Tobacco Use
- 2046400180 89
- 2046400181-0186 Pharmacoepidemiology and Drug Utilization How the Steady - State Cotinine Concentration in Cigarette Smokers Is Directly Related to Nicotine Intake
- 2046400187 90
- 2046400188-0192 Transdermal Nicotine As A Strategy for Nicotine Replacement
- 2046400193
- 2046400194-0198 Sensory Blockade of Smoking Satisfaction
- 2046400199 92
- 2046400200-0204 Brief Report Subjective Response to Cigarette Smoking Following Airway Anesthetization
- 2046400205 93
- 2046400206-0212 Intervention Strategies for Smoking Cessation the Role of Oncology Nursing
- 2046400213 94
- 2046400214-0219 Reduction of Tar, Nicotine and Carbon Monoxide Intake in Low Tar Smokers
- 2046400220 95
- 2046400221-0234 Long-Term Switching to Low-Tar Low-Nicotine Cigarettes
- 2046400235 96
- 2046400236-0239 Comment Recidivism and Self-Cure of Smoking and Obesity: An Attempt to Replicate
- 2046400240 97
- 2046400241-0249 Recidivism and Self-Cure of Smoking and Obesity
- 2046400250 98
- 2046400251-0263 Public Forum Love: Addiction or Road to Self-Realization, A Second Look
- 2046400264 99
- 2046400265-0274 Pharmacological and Non-Pharmacological Smoking Motives: A Replication and Extension
- 2046400275 100
- 2046400276-0289 Overcoming the Loss of A Love: Preventing Love Addiction and Promoting Positive Emotional Health
- 2046400290 101
- 2046400299 102
- 2046400300-0338 the Health Consequences of Smoking Nicotine Addiction A Report of the Surgeon General
- 2046400339 103
- 2046400340-0357 the Health Consequences of Smoking Chronic Obstructive Lung Disease A Report of the Surgeon General Chapter 6. Low Yield Cigarettes and Their Role in Chronic Obstructive Lung Disease
- 2046400358 104
- 2046400359 Smoking and Health Report of the Advisory Committee to the Surgeon General of the Public Health Service
- 2046400360-0369 Chapter 13 Characterization of the Tobacco Habit
- 2046400370 105
- 2046400371-0375 Is Nicotine Use An Addiction
- 2046400376 106
- 2046400377-0391 Nicotine Pharmacodynamics: Some Unresolved Issues
- 2046400392 107
- 2046400393-0400 Craving for Cigarettes
- 2046400401 108
- 2046400402 Smoker Motivation A Review of Contemporary Literature
- 2046400403-0453 Chapter 1 Trends in Cigarette Consumption and the Sociodemographic Structure of the Smoking Population in Developed Industrial Countries
- 2046400454 109
- 2046400455-0461 Increase of Circulating Beta-Endorphin-Like Immunoreactivity Correlates with the Change in Feeling of Pleasantness After Running
- 2046400462 110
- 2046400463-0469 New Data Note Series - 20 Severity of Dependence: Data From the Dsm-IV Field Trials
- 2046400470 111
- 2046400471-0479 World Health Organization Technical Report Series No. 551 Who Expert Committee on Drug Dependence Twentieth Report
- 2046400480 112
- 2046400481-0489 Cigarette Brand-Switching: Effects on Smoke Exposure and Smoking Behavior
- 2046400490
Related Documents:
Document Images
.. r. .. .. .. s .. r .. .. m.= r .. r m.. mw)
I
Suggested Citation
U.S. Department of Health and Human Serviceti. Thr Hi,alllt Bciu!/il.c ()(Smnk-
inigCessatian. U.S. Department of Health and Human Services, Public Health
Service, Centers for Disease Control, Center for Chronic Disease Prevention and
Health Promotion, Office on Smoking and Health. DHHS Publication No.
(CDC) 90-8416, 19y0.
a report of the
Surgeon General
1990
The Health Benefits
of
SMOKING CESSATION
~
U.S. DEPAR fMGN fOF ItI:AI:I II ANI) IItIMAN SIiRVI('IiS
Public I leallh Service
CEHIER! FOH DIBFA$E CONLHOI
~ / Cenler% for Disease Control
~ ( Center for Chronic Disease Prevention and 1lcaltlt Promotiom
Office on Smoking and Health
Roukville. Maryland 20857
TGZOOM99

... r. .. .. .. a. .. .. r. .. = +.. a.. r .. M .r .. W
FOREWORD
M*Jiyi' MV
More than 38 million Americans have quit smokinp cigarettes, and nearly half of all
living adults who ever smoked have quit. Unfortunately, some 50 million Americans
continue to smoke cigarettes, despite the many health education programs and anti-
smoking campaigns that have been conducted during the past quarter century, despite
the declining social acceptability of smoking, and despite the consequences of smoking
to their health.
Twenty previous reports of the Surgeon General have reviewed the health effects of
smoking. Scientific data are now available on the consequences of smoking cessation
for most smoking-related diseases. Previous reports have considered some of these
data, but this Report is the first to provide a comprehensive and unified review of this
topic.
The major conclusions of this volume are:
1. Smokingce.ssation has major and immediate health benefits for men and women
of all ages. Benefits apply to persons with and without smoking-related disease.
2. Former smokers live longer than continuing smokers. For example, persons
who quit smoking before age 50 have one-half the risk of dying in the next 15
years compared with continuing smokers.
3. Smoking cessation decreases the risk of lung cancer, other cancers, heart attack,
stroke, and chronic lung disease.
4. Women who stop smoking before pregnancy or during the first 3 to 4 months
of pregnancy reduce their risk of hacing a lo%s birth.ceight baby to that of
women who never smoked.
5. The health benefits of smoking cessation far exceed any risks from the average
5-pound (2.3-kg) weight gain or any adverse psychological effects that may
follow quitting.
With the long-standing evidence that smoking is extremely harmful to health and the
mounting evidence that smoking cessation confers major health benefits, we remain
faced with the task of developing effective strategies to curtail the use of tobacco. Two
broad categories of intervention are available: prevention of smoking initiation among
youth and smoking cessation. Resources for tobacco control are limited, and
poiicymakers must decide how best to allocate those resources to smoking prevention
and cessation.
The goal of public health is to intervene as early as possible to prevent disease,
disability, and premature death. From that standpoint, prevention of smoking initiation

~ ~ ~ ~ ~ ~ ~
'~lfould'~?i majorrrity. More than M:i,q)0 teenagers become regular smokers eurlr
thi ~in the United States. Because of the strength of nicotine addiction, sonie have
argued that public health efforts should focus on smoking prevention rather than
smoking cessation. However, this need not be an "either-or" situation.
Public health practitioners have categorized interventions into primary, secondary,
and tertiary prevention. Primary prevention generally refers to the elimination of risk
factors for disease in asymptomatic persons. Secondary prevention is defined as the
early detection and treatment of disease, and is practiced using tools such as Pap smears
and blood pressure screening. Tertiary prevention consists of measures to reduce
impairment, disability, and suffering in people with existing disease.
Smoking cessation falls under the category of primary prevention as does the
prevention of smoking initiation. Smoking cessation meets the definition of primary
prevention by reducing the risk of morbidity and premature mortality in asymptomatic
people. In addition, parents who quit smoking reduce or eliminate the risk of passive-
smoking-related disease among their children and reduce the probability that their
children will become smokers. Thus, there should be no debate about the need for
smoking prevention versus cessation-both are important.
Public awareness of the health eff ects of smoking has increased substantially through
the years. Nevertheless, important gaps in public knowledge still exist. Sonie smokers
may have failed to quit because of a lack of appreciation of the health hazards of
smoking and the benefits of quitting. In the 1987 National Health Interview Survey of
Cancer Epidemiology and Control, respondents were asked whether smoking increases
the risk of various diseases (lung cancer, cancer of the mouth and throat, heart disease,
emphysema, and chronic bronchitis) and whether smoking cessation reduces the risk.
Thirty to forty percent of smokers either did not believe that smoking increases these
risks or did not believe that cessation reduces these risks. These proportions correspond
to 15 to 20 million smokers in the United States. Clearly, our efforts to educate the
public on the health hazards of smoking and the benefits ofquitting are not yet complete.
As we continue and intensfy our efforts to inform the public of these findings, we
must make available smoking cessation programs and services to those who need them.
Although 90 percent of former smokers quit without using smoking cessation programs,
counseling, or nicotine gum, smokers who do need this assistance should have it
available. We endorse the view expressed in the Preface to the 1988 Surgeon General's
Report that treatment of nicotine addiction should be considered at least as favorably
by third-party payors as treatment of alcoholism and illicit drug addiction. Good
smoking cessation treatments can achieve abstinence rates of 20 to 40 percent at I-year
followup. Those success rates. combined with (he enormous health benefits of smoking
cessation, would likely make payment for some smoking cessation treatments cost-
beneficial. For example, research by the Centers for Disease Control suggests that a
smoking cessation program offered to all pregnant smokers could save $5 for every
dollar spent by preventing low birthweight-associated neonatal intensive care and
long-term care.
moQv9vog
- ' - = M M M M r W
This Report should galvanize the health community to stress repeatedly at everY
opportunity the value of smoking cessation to the 50 million Americans who continue
to smoke.
James 0. Mason, M.D., Dr.P.H.
Assistant Secretary for Health
Public Health Service
William L. Roper. M.D.
Director
Centers for Disease Control

.. m.. ... a. .. i.. = r ... m.m m ... .. m.. ... or.
PREFACE
This Report of the Surgeon General is the 21 st Report of the U.S. Public Healti;
Service on the health consequences of smoking and the first issued during my tenure
as Surgeon General. Whereas previous reports have focused on the health effects of
smoking, this Report is devoted to the benefits of smoking cessation.
The public health impact of smoking is enormous. As documented in the 1989
Surgeon General's Report, an estimated 390,000 Americans die each year from diseases
caused by smoking. This to11 includes 115.000 deaths from heart disease; 106,(>(}0 from
lung cancer: 31,600 from other cancers; 57,000 from chronic obstructive pulmonary
disease: 27,500 from stroke; and 52,900 from other conditions related to smoking.
More than one of every six deaths in the United States are caused by smoking. For
more than a decade the Public Health Service has identified cigarette smoking as the
most important preventable cause of death in our society.
It is clear, then, that the elimination of smoking would yield substantial benefits for
public health. What are the benefits, however, for the individual smoker who quits? A
large body of evidence has accumulated to address that question and derives from cohort
and case-control studies, cross-sectional surveys, and clinical trials. In studies of the
health effects of smoking cessation, persons classified as former smokers may include
some current smokers; this misclassification is likely to cause an underestimation of
the health benefits of quitting. Taken together, the evidence clearly indicates that
smoking cessation has major and immediate health benefits for men and women of all
ages.
Overall Benefits of Smoking Cessation
Vs9ooVM9
People who quit smoking live longer than those who continue to smoke. To what
extent is a smoker's risk of premature death reduced after quitting smoking? The
answer depends on several factors, including the number of years of smoking, the
number of cigarettes smoked per day, and the presence or absence of disease at the time
of quitting. Data from the American Cancer Society's Cancer Prevention Study 11
(CPS-11) were analyzed in this Report to estimate the risk of premature death in
ex-smokers versus current smokers. These data show, for example, that persons who
quit smoking before age 50 have one-half the risk of dying in the next 15 years compared
with continuing snrokers.
Smoking cessation increases Iife expectancy because it reduces the risk of dying from
specific smoking-related diseases. One such disease is lung cancer, the most common
cause of cancer death in both men and women. The risk of dying from lung cancer is
V

N1i= i~ i I~ i i ~
22 times higher among male smokers and 12 times higher among female smokers
compared with people who have never smoked.The risk of lung cancer declines steadily
in people who quit smoking; after 10 years of abstinence. the risk of lung cancer is about
30 to 50 percent of the risk for continuing smokers. Smoking cessation also reduces
the risk of cancers of the larynx, oral cavity, esophagus, pancreas, and urinary bladder.
Coronary heart disease (CHD) is the leading cause of death in the United States.
Smokers have about twice the risk of dying from CHD compared with lifetime
nonsmokers. This excess risk is reduced by about half among ex-smokers after only I
year of smoking abstinence and dcclines gradually thereafter. After 15 years of
abstinence the risk of C:HD is similar to that of persons who have never smoked.
Compared with lifetime nonsmokers, smokers have about twice the risk of dying from
stroke, the third leading cause of death in the United States. Atter quitting smoking,
the risk of stroke returns to the level of people who have never snroked; in some studies
this reduction in risk has occurred within 5 years, but in others as long as 15 years of
abstinence were required.
Cigarette smoking is the major cause of chronic obstructive pulmonary disease
(COPD). the fifih leading cause of death in the United States. Smoking increases the
risk ofCOPD by accelerating tlre age-related decline in lung function. With sustained
abstinence from smoking, the rate of decline in lung function among former smokers
returns to that of never smokers, thus reducing the risk of developing COPD.
Influenza and pneumonia represent the sixth leading cause of death in Ihe United
States. Cigarette smoking increases the risk of respiratory infections such as influenza,
pneumonia, and bronchitis, and smoking cessation reduces the risk.
Cigarette smoking is a major cause of peripheral ariery occlusive disease. This
condition causes substantial mortality and morbidity; complications may include inter-
mittent claudication, tissue ischernia and gangrene, and ultimately, loss of limb.
Smoking cessation substantially reduces the risk of peripheral artery occlusive disease
compared with continued sntoking.
The mortality rate from abdominal aortic aneurysm is two to five times higher in
current smokers than in never smokers. Former sniokers have half the excess risk of
dying from this condition relative to current snrokers.
About 2(1 million Americans currently have, or have had, an ulcer of the stomach or
duodenum. Smokers have an increased risk of developing gastric or duodenal ulcers,
and this increased risk is reduced by quitting smoking.
Benefits at All Ages
According to a 1989 Gallup survey, the proportion of smokers who say they would
like to give up snroking is lower for smokers aged 50 and older (57 percent) than for
smokers aged 18-29 (68 percent) and 30-49 (67 percent). Older smokers may be less
nrotivated to quit smoking because the highly motivated may have quit already at
younger ages. leaving a relatively "hard-core" group of ulder smokers. But many
long-tenn smokers may lack motivation to quit for other reasons. Some nray believe
they are no longer at risk of smoking-related diseases because they have already
survived smoking for many years. Others may believe that any damage that may have
i i ! i i i M i = M
been caused by smoking is irreversible after decades of smoking. For similar reatioirs.
many physicians may be less likely to counsel their older patients to quit.
CPS-11 data were used to estimate the effects of quitting smoking at various ages on
the cumulative risk of death during a fixed interval after cessation. The results show
that the benefits of cessation extend to quitting at older ages. For example, a healthy
man aged 60-64 who smokes I pack of cigarettes or more per day reduces his risk of
dying during the next 15 years by 10 percent if he quits smoking.
I
These findings support the recommendations of the Surgeon General s IyxR
Workshop on Health Promotion and Aging for the development and etissemination (.f
smoking cessation messages and interventions to older persons. I am pleased that a
coalition of organizations and agencies is now working toward implementation of those
recommendations, including the Centers for Disease Control; the National Cancer
Institute; the National Heart, Lung, and Blood Institute; the Administration on Aging,;
the Department of Veterans Affairs; the Office of Disease Preveittion and Health
Promotion; the American Association of Retired Persons; and the Fox Chase Cancer
Center. The major message of this campaign will he that it is never too late to quit
smoking.
Two facts point to the urgent need for a strong smoking cessation canipaign targeting
older Americans: (1) 7 mi Ilion smokers are aged 60 or older; and (2) smoking is a niajor
risk factor for 6 of the 14 leading causes of death among those aged 60 and older, and
is a complicating factor for 3 others.
Benefi.ts for Smokers with Existing Disease
Many smokers who have already developed smoking-related disease or symptoms
may be less motivated to quit because of a belief that the damage is already done. For
the same reason, physicians may be less motivated to advise these patients to quit.
However, the evidence reviewed in this Report shows that smoking cessation yields
important health benefits to those who already suffer from smoking-related illness.
Among persons with diagnosed CHD. smoking cessation markedly reduces the risk
of recurrent heart attack and cardiovascular death. In many studies, this reduction in
risk has been 50 percent or more. Smoking cessation is the nrost important intervention
in the management of peripheral artery occlusive disease; for patients with this condi-
tion, quitting smoking improves exercise tolerance, reduces the risk of amputation
peripheral artery surgery, and increases overall survival. Patients with gastric and
duodenal ulcers who stop smoking improve their clinical course relative to smokers
who continue to smoke. Although the benefits of smoking cessation among stroke
patients have not been studied, it is reasonable to assume that quitting smoking reduces
the risk of recurrenl stroke just as it reduces the risk of recurrence of othercardiovascul.r
events.
Even smokers who have already developed cancer may benefit from smoking
cessation. A few studies have shcrwn that persons who stopped smoking after diagnosis
of cancer had a reduced risk of acquiring a second primary cancer compared a-ith
persons who continued to smoke. Although relevant data are sparse, longer survival
might be expected among smokers with cancer or other serious illnesses if they stop
vi

M M,m ..~ s r ~ No ~ -~ an W ~ tr.c- ~ ~ ~ ~. ~
smoking. Smoking cessation reduces the risk of respiratory infections such as
pneumonia, which are often the immediate causes of death in patients with an under-
lying chronic disease.
The important role of health care providers in counseling patients to quit smoking is
well recognized. Health care providers should give smoking cessation advice and
assistance to all patients who smoke, including those with existing illness.
Benefits for the Fetus
Benefits for Infants and Children
As a pediatrician. I am particularly concemed about the effects of parental smoking
on infants and children. Evidence reviewed in the 1986 Surgeon General's Report. T>+te
Heallh CGmseqrrenre.c t?f Imnlunlary Smoking, indicates that the children of parents
who smoke, compared with the children of nonsmoking parents, have an increased
frequency of respiratory infections such as pneumonia and bronchitis. Many studies
have found a dose-response relationship between respiratory illness in children and
their level of tobacco smoke exposure.
Several studies have shown that children exposed to tobacco smoke in the home are
more likely to develop acute otitis media and persistent middle ear effusions. Middle
ear disease impmes a substantial burden on the heaUh care system. Otitis media is the
most frequent diagnosis made by physicians who care for children. The myringotomy-
and-tube procedure, used to treat otitis media in more than I million American children
each year, is the most common minor surgical operation performed under general
anesthesia.
The impact of smoking cessation during or after pregnancy on these associations has
not been studied. flowever, the dose-response relationship between parental smoking
and frequency of childhood respiratory infections suggests that smoking cessation
during pregnancy and abstinence after delivery would eliminate most or all of the excess
risk by eliminating most or all of the exposure.
If parents are unwilling to quit smoking for their own sake, I would urge them to quit
for the sake of their children. Passive-smoking-induced infections in infants and year.g
children can cause serious and even fatal illness. Moreover, children whose parents
smoke are much more likely to become smokers themselves.
Maternal smoking is associated with several complications of pregnancy including
abruptio placentae, placenta previa, bleeding during pregnancy, premature and
prolonged rupture of the membranes, and preterm delivery. Maternal smoking retards
fetal growth, causes an average reduction in birthweight of 200 g, and doubles the risk
of having a low birthweight baby. Studies have shown a 25- to 50-percent higher rate
of fetal and infant deaths among women who smoke during pregnancy compared with
those who do not.
Women who stop smoking before becoming pregnant have infants of the same
birthweight as those born to women who have never smoked. The same benefit accrues
to women who quit smoking in the first 3 to 4 months of pregnancy and who remain
abstinent throughout the remainder of pregnancy. Women who quit smoking at later
stages of pregnancy, up to the 30th week of gestation, have infants with higher
birthweight than do women who smoke throughout pregnancy.
Smoking is probably the most important modifiable cause of poorpregnancy outcome
among women in the United States. Recent estimates suggest that the elimination of
smoking during pregnancy could prevent about 5 percent of perinatal deaths, about 20
percent of low birthweight births, and about 8 percent of preterm deliveries in the United
States. In groups with a high prevalence of smoking (e.g., women who have not
completed high school), the elimination of smoking during pregnancy could prevent
about 10 percent of perinatal deaths, about 35 percent of low hirthweight births, and
about 15 percent of preterm deliveries.
The prevalence of smoking during pregnancy has declined over time but remains
unacceptably high. Approximately 30 percent of U.S. women who are cigarette
smokers quit after recognition of pregnancy, and others quit later in pregnancy.
However, about 25 percent of pregnant women in the United States smoke throughout
pregnancy. A shocking statistic is that half of pregnant women who have not completed
high school smoke throughout pregnancy. Many women who do not quit smoking
during pregnancy reduce their daily cigarette consumption; however, reduced con-
sumpt:,:n without quitting may have little or no benefit for birthweight. Of the women
who quit smoking during pregnancy, 70 percent resume smoking within I year of
delivery.
Initiatives have been launched in the public and private sectors to reduce smoking
during pregnancy. These programs should be expanded, and less educated pregnant
women should be a special target of these efforts. Strategies need to be developed to
address the problem of relapse after delivery.
9V (~~ 'J 0,Y + 1 IV J (.!
I
Smoking Cessation and Weight (:ain
The fear of postcessation weight gain may discourage many smokers from trying to
quit. The fear or occurrence of weight gain may precipitate relapse among many of
those who already have quit. In the 1986 Adult Use ofTobacco Survey. current smokers
who had tried to quit were asked to judge the importance of several possible reasons
for their return to smoking. Twenty-seven percent reported that "actual weight gain"
was a "very important" or "somewhat important" reason why they resumed smoking;
22 percent said that "the possibility of gaining weight" was an important reason for
their relapse. Forty-seven percent of current smokers and 48 percent of former smokers
agreed with the statement that "smoking helps control weight."
Fifteen studies involving a total of 20,(HK) persons were reviewed in this Report t,,
determine the likelihood of gaining weight and the average weight gain after quitting.
Although four-fifths of smokers who quit gained weight after cessation, the average
weight gain was only 5 pounds (2.3 kg). The average weight gain among subjects who
continued to smoke was I pound. Thus, smoking cessation produces a 4-pound greater
weight gain than that associated with continued smoking. This weight gain pose% a
minimal health risk. Moreover, evidence suggests that this small weight gain is
accompanied by favorable changes in lipid profiles and in body fat distribution.

~ ~ ~
'SfRirkin~ation M M ~ ~
~1ratns-and messages should emphasize that weight gain after
quitting is small on average.
Not only is the average postcessation weight gain small, but the risk of large weight
gain after quilting is extremely low. Less than 4 percent of those who quit smoking
gain more than 20 pounds. Nevertheless, special advice and assistance should be
available to the rare person who does gain considerable weight after quitting. For these
individuals, the health benefits of cessation still occur, and weight control programs
rather than smoking relapse should be implemented.
Increases in food intake and decreases in resting energy expenditure are largely
responsible for postcessation weight gain. Thus, dietary advice and exercise should be
helpful in preventing or reducing postcessation weight gain. Unfortunately, minor
weight control modifications to smoking cessation programs do not generally yield
beneficial effects in terms of reducing weight gain or increasing cessation rates. A few
studies have investigated pharmacofogic approaches to postcessation weight control;
preliminary results are encouraging but more research is needed. High priority should
be given to the development and evaluation of effective weight control programs that
can be targeted in a cost-effective manner to those at greatest need of assistance.
Psychological and Behavioral Consequences of Smoking Cessation
Nicotine withdrawal symptoms include anxiety, irritability, frustration, anger, dif-
ficulty concentrating, increased appetite, and urges to smoke. With the possible
exception of urges to smoke and increased appetite, these effects soon disappear.
Nicotine withdrawal peaks in the first I to 2 days following cessation and subsides
rapidly during the following weeks. With long-term abstinence, fonner smokers are
likely to enjoy favorable psychological changes such as enhanced self-esteem and
increased sense of self control.
Although most nicotine withdrawal symptoms are short-lived, they often exert a
strong influence on smokers' ability to quit and maintain abstinence. Nicotine
withdrawal may discourage many smokers from trying to quit and may precipitate
relapse among those who have recently quit. In the 1986 Adult Use of Tobacco Survey.
39 percent of' current smokers reported that irritability was a "very important" or
"somewhat important" reason why they resumed smoking after a previous quit attempt.
Smokers and ex-smokers should be counseled that adverse psychological effects of
smoking subside rapidly over time. Smoking cessation materials and programs,
nicotine replacement, exercise, stress management, and dietary counseling can help
smokers cope with these symptoms until they abate, after which favorable psychologi-
cal changes are likely to occur.
Support for a Causal Association Between Smoking and 1)isease
Tens of thousands of studies have documented the associations between cigarette
smoking and a large number of serious diseases. It is safe to say that sntoking represents
the most extensively documented cause of disease ever investigated in the history of
biomedical research.
+~ #= 4M M IM ~ ~ ~ 4M P!
Previous Surgeon General's reports, in particular the landmark tyo4 Report of the
Surgeon General's Advisory Committee on Smoking and Health and the 1982 Surgeon
General's Report on smoking and cancer, examined these associations with respect 10
the epidemiologic criteria forcausality. These criteria include the consistency, strength,
specificity, coherence, and temporal relationship of the association. Based on these
criteria, previous reports have recognized a causal association between smoking and
cancers of the lung, larynx, esophagus, and oral cavity; heart disease; stroke; peripheral
I
artery occlusive disease: chronic obstructive pulmonary disease; and intrauternne
growth retardation. This Surgeon General's Report is the first to conclude that the
evidence is now sufficient to identify cigarette smoking as a cause of cancer of the
urinary bladder; the 1982 Report concluded that cigarette smoking is a contributing
factor in the development of bladder cancer.
The causal nature of most of these associations was well established long before
publication of this Report. Nevertheless, it is worth noting that the findings of this
Report add even more weight to the evidence that these associations are causal. The
criterion of coherence requires that descriptive epidemiologic findings on disease
occurrence correlate with measures of exposure to the suspected agent. Coherence
would predict that the increased risk of disease associated with an exposure would
diminish or disappear after cessation of exposure. As this Report shows in great detail,
the risks of most smoking-related diseases decrease after cessation and with increasing
duration of abstinence.
Evidence on the risk of disease after smoking cessation is especially important for
the understanding of sntoking-and-disease associations of unclear causality. For ex-
ample, cigarette smoking is associated with cancer of the uterine cervix, but this
association is potentially confounded by unidentified factors (in particular by a sexually
transmitted etiologic agent). The evidence reviewed in this Report indicates that former
smokers experience a lower risk of cervical cancer than current smokers, even after
adjusting for the social correlates of smoking and risk of sexually acquired infections.
This diminution of risk after smoking cessation supports the hypothesis that smoking
is a contributing cause of cervical cancer.
Conclusion
The Comprehensive Smoking Education Act of 1984 (Public Law 98-474) requires
the rotation of four health warnings on cigarette packages and advertisements. One of
those warnings reads. "SURGEON GENERAL'S WARNING: Quitting Smoking
Now Greatly Reduces Serious Risks to Your Health." The evidence reviewed in this
Report confirms and expands that advice.
The health benefits of quitting smoking are immediate and substantial. They far
exceed any risks from the average 5-pound weight gain or any adverse psychological
effects that may follow quitting. The benefits extend to men and women, to the young
and the old, to those who are sick and to those who are well. Smoking cessation
represents the single most important step that smokers can take to enhance the length
and quality of their lives.

-'-hcion- i' ~ M M ~ ~ ~ ~ ~ ~ ~ ~.~ 1~ M ~ '~ ~
Pub p po is tell us that most smokers want to quit. This Report provides
smokers with new and more powerful motivation to give up this self-destructive
behavior.
ACKNOWLEDGMENTS
Antonia C. Novello. M.D.. M.P.H.
Surgeon General
M'3 V Y:,7 Y.7 9
This Report was prepared by the Department of Health and Human Services under
the general editorship of the Office on Smoking and Health, Ronald M. Davis, M.D,
, Director. The Managing Editor was Susan A. Hawk, Ed.M., M.S.
Tlte sciciUific editrnv.c n(the Reprnt were:
Jonathan M. Samet, M.D. (Senior Scientific Editor), Professor of Medicine and Chief,
Pulmonary Division. Department of Medicine and the New Mexico Tumor Registry.
Cancer Center, University of New Mexico, Albuquerque, New Mer ico
Ronald M. Davis, M.D., Director, Office on Smoking and Health, Center for Chronic
Disease Prevention and Health Promotion (CCDPHP), Centers for Disease Control
(CDC). Rockville, Maryland
Neil E. Grunberg, Ph.D., Professor, Department of Medical Psychology, Uniformed
Services University of the Health Sciences, Bethesda, Maryland
Judith K. Ockene. Ph.D., Professor of Medicine, and Director, Division of Preventive
and Behavioral Medicine, Department of Medicine, University of Massachusetts
Medical School, Worcester. Massachusetts
Diana B. Petitti, M.D., M.P.H., Associate Professor, Department of Family and Com-
munity Medicine, University of California at San Francisco. School of Medicine, San
Francisco, California
Walter C. Willett, M.D., Dr.P.H., Professor of Epidemiology and Nutrition, Harvard
School of Public Health, and The Channing Laboratory, Department of Medicine,
Harvard Medical School and Brigham and Women's Hospital, Boston, Mas-
sachusetts
The foNrnrin,q indiridiiaLc prepared draft chapters or portions of the Report:
Robert Anda, M.D., Epidemiologist. Office of Surveillance and Analysis, CCDPHP;
CDC. Atlanta, Georgia
John Baron, M.D.. Associate Professor of Medicine, Department of Medicine.
Dartmouth Medical School, Hanover, New Hampshire
Tim Byers, M.D.. M.P.H., Chief, Epidemiology Branch, Division of Nutrition.
CCDPHP, CDC. Atlanta. Georgia
Arden G. Christen, D. D.S., M.S.D., M.A., Chairman, Professor, Department of Preven-
tive and Community Dentistry, Indiana University School of Dentistry, Indianapolis,
Indiana
Graham Colditz, Dr.P.H., Assistant Professor of Medicine, Harvard School of Public
Health, and the Channing Laboratory, Department of Medicine, Harvard Medical
School and Brigham and Women's Hospital, Boston, Massachusetts
xii
